Exploring Pharmacogenomic Testing and Clinical Decision-Making in Local Mental Health Facilities

Abstract

This research project addresses the clinical question: How are local mental health facilities using pharmacogenomic testing information to make clinical decisions? In order to answer this question, the student investigator conducted a descriptive study to explore the use of pharmacogenomic testing by local mental health facility providers. The student investigator and faculty chair created a data form including demographics and survey questions that included both open and closed-ended questions. The survey was sent to 40 providers at various MHMR (My Health My Resources) clinics. Nurse practitioners and physicians were asked questions pertinent to how they felt pharmacogenomic testing has impacted their clinical decisions and patient experience. Survey results reveal that very few providers implement pharmacogenomic testing regularly. Providers expressed concerns such as lack of scientific evidence, high cost, and lack of new information for treatment as reasons testing is not routine. Although a limited sample was used, the findings suggest a need for further research to determine barriers to pharmacogenomic testing and incorporation of results into clinical decision-making.